These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22469285)

  • 1. Diagnosis and assessment of apathy in Chinese patients with Alzheimer's disease.
    Zhao H; Zhao Z; Huang L; Preter M
    J Psychosom Res; 2012 May; 72(5):405-7. PubMed ID: 22469285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments.
    Lanctôt KL; Scherer RW; Li A; Vieira D; Coulibaly H; Rosenberg PB; Herrmann N; Lerner AJ; Padala PR; Brawman-Mintzer O; van Dyck CH; Porsteinsson AP; Craft S; Levey A; Burke WJ; Mintzer JE
    Am J Geriatr Psychiatry; 2021 Jan; 29(1):81-89. PubMed ID: 32565008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic criteria for apathy in clinical practice.
    Mulin E; Leone E; Dujardin K; Delliaux M; Leentjens A; Nobili F; Dessi B; Tible O; Agüera-Ortiz L; Osorio RS; Yessavage J; Dachevsky D; Verhey FR; Cruz Jentoft AJ; Blanc O; Llorca PM; Robert PH
    Int J Geriatr Psychiatry; 2011 Feb; 26(2):158-65. PubMed ID: 20690145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.
    Kaufer DI; Cummings JL; Christine D; Bray T; Castellon S; Masterman D; MacMillan A; Ketchel P; DeKosky ST
    J Am Geriatr Soc; 1998 Feb; 46(2):210-5. PubMed ID: 9475452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Icelandic version of the Neuropsychiatric Inventory with Caregiver Distress (NPI-D).
    Davidsdottir SR; Snaedal J; Karlsdottir G; Atladottir I; Hannesdottir K
    Nord J Psychiatry; 2012 Feb; 66(1):26-32. PubMed ID: 21770826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer's disease.
    Hsieh CJ; Chu H; Cheng JJ; Shen WW; Lin CC
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):227-34. PubMed ID: 22443245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of behavioral and psychological symptoms on caregiver burden in frontotemporal dementia, Lewy body dementia, and Alzheimer's disease: clinical experience in China.
    Liu S; Jin Y; Shi Z; Huo YR; Guan Y; Liu M; Liu S; Ji Y
    Aging Ment Health; 2017 Jun; 21(6):651-657. PubMed ID: 26882509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Assessment of Apathy in Elderly Chinese Patients With Cerebral Small Vessel Disease.
    Zhào H; Liu Y; Xia Z; Xie H; Huang Y
    Front Psychiatry; 2021; 12():688685. PubMed ID: 34413797
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical characteristics according to depression screening tools in patients with Alzheimer's disease: view from self, caregiver-reported and drug-intervention pattern.
    Kwak YT; Yang Y; Pyo SJ; Koo MS
    Geriatr Gerontol Int; 2014 Jul; 14(3):660-6. PubMed ID: 24118908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Most families tend to realize progress of Alzheimer's disease when behavioural and psychological symptoms are obvious.
    Honjo Y; Ide K; Takechi H
    Psychogeriatrics; 2022 May; 22(3):317-323. PubMed ID: 35146847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anosognosia and neuropsychiatric symptoms on the quality of life of patients with Alzheimer's disease: a 24-month follow-up study.
    Conde-Sala JL; Turró-Garriga O; Piñán-Hernández S; Portellano-Ortiz C; Viñas-Diez V; Gascón-Bayarri J; Reñé-Ramírez R
    Int J Geriatr Psychiatry; 2016 Feb; 31(2):109-19. PubMed ID: 25963296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caregiver rating bias in mild cognitive impairment and mild Alzheimer's disease: impact of caregiver burden and depression on dyadic rating discrepancy across domains.
    Pfeifer L; Drobetz R; Fankhauser S; Mortby ME; Maercker A; Forstmeier S
    Int Psychogeriatr; 2013 Aug; 25(8):1345-55. PubMed ID: 23651733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuropsychiatric inventory scores change across the mini mental state examination ranges in patients with Alzheimer's disease: a multicenter study in Turkey.
    Yener GG;
    Cogn Behav Neurol; 2009 Dec; 22(4):264-9. PubMed ID: 19996880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of patient and caregiver predictors for caregiver burden, anxiety and depression in Alzheimer's disease.
    Lou Q; Liu S; Huo YR; Liu M; Liu S; Ji Y
    J Clin Nurs; 2015 Sep; 24(17-18):2668-78. PubMed ID: 26108739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of family caregiver ratings of patient quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study.
    Naglie G; Hogan DB; Krahn M; Black SE; Beattie BL; Patterson C; Macknight C; Freedman M; Borrie M; Byszewski A; Bergman H; Streiner D; Irvine J; Ritvo P; Comrie J; Kowgier M; Tomlinson G
    Am J Geriatr Psychiatry; 2011 Oct; 19(10):891-901. PubMed ID: 21946805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese Version of the Baylor Profound Mental Status Examination: A Brief Staging Measure for Patients with Severe Alzheimer's Disease.
    Fu X; Yu W; Ke M; Wang X; Zhang J; Luo T; Massman PJ; Doody RS; Lü Y
    J Prev Alzheimers Dis; 2021; 8(2):175-180. PubMed ID: 33569564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity.
    Tatsch MF; Bottino CM; Azevedo D; Hototian SR; Moscoso MA; Folquitto JC; Scalco AZ; Louzã MR
    Am J Geriatr Psychiatry; 2006 May; 14(5):438-45. PubMed ID: 16670248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression in Taiwanese patients with Alzheimer's disease determined by the National Institutes of Mental Health Provisional Criteria.
    Chiu PY; Steffens D; Chen PK; Hsu YC; Huang HT; Lai TJ
    Int Psychogeriatr; 2012 Aug; 24(8):1299-305. PubMed ID: 22333495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of neuropsychiatric symptoms of Alzheimer's disease on Chinese and American caregivers.
    Pang FC; Chow TW; Cummings JL; Leung VP; Chiu HF; Lam LC; Chen QL; Tai CT; Chen LW; Wang SJ; Fuh JL
    Int J Geriatr Psychiatry; 2002 Jan; 17(1):29-34. PubMed ID: 11802227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.
    Senanarong V; Cummings JL; Fairbanks L; Mega M; Masterman DM; O'Connor SM; Strickland TL
    Dement Geriatr Cogn Disord; 2004; 17(1-2):14-20. PubMed ID: 14560060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.